EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Chimeric antigen receptor T‐cells: Properties, production, and quality control

Pooja Ramesh, Henry Y L Hui, Leon M Brownrigg, Kathy A Fuller, Wendy N Erber iD

International Journal of Laboratory Hematology · 2023-08 · 45 (4) · 425-435

DOI: 10.1111/ijlh.14121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 20.06.2023. Verfasst von Pooja Ramesh und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Multiple Myeloma, Antineoplastic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T‐cell therapy is a novel adoptive T‐cell immunotherapy for haematological malignancies. First introduced into clinical practice in 2017, CAR T‐cell therapy is now finding its place in the management of lymphoid malignancies, primarily of B‐cell lineage, including lymphoblastic leukaemia, non‐Hodgkin lymphoma and plasma cell myeloma, with remarkable therapeutic outcomes. CAR T‐cells are a customised therapeutic product for each patient. Manufacture commences with collection of autologous T‐cells, which are then genetically engineered ex vivo to express transmembrane CARs. These chimeric proteins consist of an antibody‐like extracellular antigen‐binding domain, to recognise specific antigens on the surface of tumour cells (e.g. CD19), linked to the intracellular co‐stimulatory signalling domains of a T‐cell receptor (e.g. CD137). The latter is required for in vivo CAR T‐cell proliferation, survival, and durable efficacy. Following reinfusion, CAR T‐cells harness the cytotoxic capacity of a patient's immune system. They overcome major mechanisms of tumour immuno‐evasion and have potential to generate robust cytotoxic anti‐tumour responses. This review discusses the background to CAR T‐cell therapies, including their molecular design, mechanisms of action, methods of production, clinical applications and established and emerging technologies for CAR T‐cell evaluation. It highlights the need for standardisation, quality control and monitoring of CAR T‐cell therapies, to ensure their safety and efficacy in clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenMultiple MyelomaAntineoplastic AgentsHumansReceptors, Antigen, T-CellT-LymphocytesQuality Control

Stichwörter der Autor:innen

CAR T-cellimaging flow cytometryimmunotherapyleukaemialymphoma

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-CellAntineoplastic Agents

Autor:innen und Institutionen

  • School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia.
  • Cell and Tissue Therapies WA, Royal Perth Hospital, Perth, Western Australia, Australia.
  • Haematology, PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.

ORCID-Profile: Wendy N Erber

Zitieren

APA

Ramesh, P., Hui, H. Y. L., Brownrigg, L. M., Fuller, K. A., & Erber, W. N. (2023). Chimeric antigen receptor T‐cells: Properties, production, and quality control. International Journal of Laboratory Hematology, 45(4), 425-435. https://doi.org/10.1111/ijlh.14121

Vancouver

Ramesh P, Hui HYL, Brownrigg LM, Fuller KA, Erber WN. Chimeric antigen receptor T‐cells: Properties, production, and quality control. International Journal of Laboratory Hematology. 2023;45(4):425-435. doi:10.1111/ijlh.14121

BibTeX
@article{Ramesh2023,
  author = {Ramesh, Pooja and Hui, Henry Y L and Brownrigg, Leon M and Fuller, Kathy A and Erber, Wendy N},
  title = {Chimeric antigen receptor T‐cells: Properties, production, and quality control},
  journal = {International Journal of Laboratory Hematology},
  year = {2023},
  volume = {45},
  number = {4},
  pages = {425--435},
  doi = {10.1111/ijlh.14121}
}
Kostenlos starten →